QNRX Quoin Pharmaceuticals, Ltd.
Healthcare$4.77-1.65%ClosedMarket Cap: $2.8M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.07
P/S
0.00
EV/EBITDA
0.02
DCF Value
$2,547.49
FCF Yield
-565.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-292.3%
ROA
-108.2%
ROIC
-168.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-5.1M | $-5.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.5M | $-4.3M | $— | — |
| FY null | $0.00 | NaN% | $-16.3M | $-15.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.0M | $-3.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.8M | $-3.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.0M | $-3.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.4M | $-2.3M | $— | — |
| FY null | $0.00 | NaN% | $-9.5M | $-9.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.5M | $-2.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.1M | $-2.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.5M | $-2.3M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-2.2M | $-2.0M | $-2.10 | — |